neuroflash Digital Twins is a self-service platform for synthetic audiences built on more than 1,000,000 real survey and profile data points collected since 2017, with some twins carrying up to 250 answered questions, used by marketers to test LinkedIn posts, CTAs, landing pages, and images before publishing. Simile is an enterprise AI simulation platform grown out of Stanford research, building “agentic twins” modeled on real people so organizations like CVS Health can replace multi-week research programs with simulated surveys run in minutes.[1] Both promise to swap slow, expensive human research for AI-simulated people, but they sit at opposite ends of the market. Simile is a $2 billion, VC-backed platform for population-scale behavioral simulation, sold exclusively through enterprise sales teams.[2] neuroflash Digital Twins is built for marketers who want to start testing content in minutes, plug results into their existing AI stack through API and MCP, and never need a seven-figure contract to find out whether an idea will land.
This article compares both on methodology, validation, pricing access, and fit. If you are evaluating other providers too, see our comparisons of neuroflash vs. Evidenza and neuroflash vs. Synthetic Users, or the broader overview in our Digital Twins market research hub.
Key Takeaways
- Simile’s peer-reviewed 85% accuracy figure describes GSS survey-replication consistency versus human test-retest, not how well twins predict reactions to marketing content.[3]
- Simile is enterprise, sales-led only. No public pricing exists, and the one contract visible on AWS Marketplace lists $15,000,000 for a 36-month term.[4]
- neuroflash Digital Twins are self-service and free to start at app.neuroflash.com, with results in minutes instead of the 4-8 weeks classic fieldwork typically takes.
- neuroflash reaches 85-98% prediction accuracy in customer pilots, including 98% on 22 Essity product claims, against roughly 55% for generic ChatGPT roleplay, validated across 80+ academic studies.
- Public validation of Simile’s accuracy comes largely from parties with a financial stake in its success: CVS Health is both customer and investor, Gallup is a data partner.[5]
- neuroflash integrates via API and MCP into ChatGPT, Claude, Copilot, and Langdock from the Pro plan; no public API or integration documentation exists for Simile.[1]
How Does Simile Build Its Agentic Twins?
Simile builds its agentic twins by combining two-hour qualitative interviews with roughly 1,000 to 1,052 representative participants with a training corpus of 2.9 million responses from 210 social-science experiments, then fine-tuning and weekly recalibrating the agents so they answer the way the people they model would.[3] The methodology traces to Stanford research: the 2023 paper “Generative Agents: Interactive Simulacra of Human Behavior” and its 2024 follow-up “Generative Agent Simulations of 1,000 People,” led by CEO Joon Sung Park with Michael Bernstein and Percy Liang, published through Stanford HAI.[3] Simile later expanded the base cohort through a Gallup partnership, adding “a few million” more people, and twins are also trained on users’ own chat histories plus behavioral, purchasing, and (for clients like CVS) internal survey data, under guardrails such as role-based access control.[6] The architecture is multi-agent, so twins interact with each other rather than only answering isolated prompts.
The flagship reference case is CVS Health: twins built on 2.9 million consented responses from more than 400,000 real people across 200+ behavioral scenarios, running 100,000+ agentic twins to compress 4-6 week research studies into 15-30 minutes.[7] That speed gain explains the capital behind Simile’s traction. It does not change access, though: Simile is enterprise-only and sales-led, with no self-serve signup or plan page.[4]
neuroflash Digital Twins: Self-Service Testing for Marketing Content
neuroflash takes a different starting point: instead of simulating populations for strategic research, it builds synthetic audiences from more than 1,000,000 real survey and profile data points collected since 2017, with individual twins carrying up to 250 answered questions, so marketers can test concrete content before it goes live. Core capabilities include Chat with your Audience for open-ended dialogue with a twin segment, content tests for posts, CTAs, and landing pages, image feedback through NeuroLens with up to 96% gaze prediction, text and slogan scoring through NeuroWords, A/B comparisons, and automated content workflows.
The platform is self-service and free to start at app.neuroflash.com, with DACH roots and a GDPR and EU-hosting focus, available in German and English. Results come back in minutes rather than the 4-8 weeks classic fieldwork usually requires. From the Pro plan, API and MCP access lets teams plug twins directly into ChatGPT, Claude, Copilot, Langdock, and other agents already in use. neuroflash functions as the digital twin research layer that plugs into whatever AI stack a team already has, rather than as its own LLM chatbot or ChatGPT alternative.
neuroflash vs. Simile at a Glance
| Criterion | neuroflash Digital Twins | Simile |
|---|---|---|
| Data Basis | 1,000,000+ real survey/profile data points since 2017, up to 250 questions per twin | ~1,000-1,052 interviewed participants plus 2.9M experiment responses, expanded via Gallup[3] |
| Methodology | Proprietary twin modeling on structured survey/profile data | Generative agents, multi-agent architecture, weekly recalibration[3] |
| Accuracy/Validation | 85-98% in customer pilots (98% on 22 Essity claims), 80+ studies, vs ~55% generic ChatGPT | Claims 85-99%; peer-reviewed figure is GSS survey-replication vs human test-retest, not marketing[3] |
| Use Cases | Marketing content: posts, CTAs, landing pages, images, slogans | Enterprise decision simulation: healthcare, policy, finance, litigation[7] |
| Pricing Model/Access | Self-service, free to start | Sales-led only, unpublished, one AWS listing at $15M/36 months[4] |
| Target Customer | Marketers and content teams of any size | Large enterprises with dedicated research budgets[7] |
| Languages/EU | German and English, GDPR/EU-hosting focus | Not publicly documented; US-based clients |
Simile’s Accuracy Claim: What the 85% Number Really Means
Simile’s public messaging states 85-99% accuracy “depending on the group,” backed by a proprietary confidence model.[8] The peer-reviewed source behind that number is narrower than the headline suggests: the 2024 Stanford study found that generative agents replicated participants’ own General Social Survey answers with 85% of the accuracy that the same humans replicated their own answers two weeks later.[3] Agents approached, but did not exceed, human test-retest consistency on one specific survey instrument. It is not a measurement of how well twins predict reactions to an ad, a product claim, or a piece of marketing copy.
Two further gaps deserve mention, stated factually rather than as a dig. Simile’s proprietary confidence-scoring model has no independently disclosed performance data; one critical analysis describes it as currently “a UX affordance” rather than verified infrastructure.[8] And no independent or adversarial third-party evaluation of Simile’s accuracy is publicly available: the public voices vouching for it both have a financial stake in the outcome, CVS Health as customer and investor through CVS Health Ventures, Gallup as data partner rather than neutral evaluator.[5] None of this means the technology does not work. It means the 85% figure describes something narrower than “predicts what your customers will do.”
When Is Simile the Better Choice?
Simile is the better choice for large enterprises running population-scale behavior simulation with a seven-figure research budget. Its named client base, CVS Health, Gallup, Deloitte, and Wealthfront, points to healthcare, policy research, and financial services, where organizations need to model how tens or hundreds of thousands of people might respond to a medication adherence program, a policy change, or a litigation scenario, not just how a single piece of content performs. The multi-agent architecture, where twins interact with each other, is methodologically closer to real social dynamics than isolated prompt-response testing.
The funding trajectory reflects that positioning: a $100M Series A led by Index Ventures in February 2026, followed roughly five months later by a $200M Series B at a $2 billion post-money valuation led by Greenoaks, with CVS Health Ventures among the participants.[2] If your organization has the budget and runway for a sales-led enterprise implementation, and your need is strategic population simulation rather than iterative content testing, Simile’s academic pedigree and enterprise-scale infrastructure are a legitimate fit.
When Are neuroflash Digital Twins the Better Choice?
neuroflash Digital Twins fit teams that need to test concrete marketing content, posts, CTAs, images, landing pages, and want an answer in minutes rather than a multi-month sales cycle. There is no seven-figure contract to negotiate: you can start free at app.neuroflash.com and see results the same day. If your workflow already runs through ChatGPT, Claude, Copilot, or Langdock, API and MCP access from the Pro plan lets twins plug directly into that stack. And when accuracy on marketing content specifically matters more than survey-replication accuracy, the 98% figure from the Essity case study speaks to that exact use case.
In the same spirit of fairness applied to Simile above: neuroflash Digital Twins are built for marketing content testing, not for simulating national elections, modeling 100,000 interacting agents, or replacing large-scale academic survey research. For that requirement, Simile’s infrastructure is purpose-built. For testing what to publish next week, neuroflash is the more direct fit.
How neuroflash Digital Twins Fit Into Your Testing Workflow
Before a post, CTA, or campaign goes live, Digital Twins show you how your actual audience is likely to react, built on more than 1,000,000 real profiles and reaching 85-98% prediction accuracy in customer pilots, against roughly 55% for generic ChatGPT roleplay, validated across 80+ academic studies. Instead of waiting weeks for a panel, you get a read in minutes.
Because twins are accessible through API and MCP from the Pro plan, they integrate directly into the AI stack your team already uses, ChatGPT, Claude, Copilot, or Langdock, so audience feedback becomes part of the content workflow rather than a separate research step.
Start for free at app.neuroflash.com and test your first piece of content today. No sales call required.
- 1,000,000+ real profiles, up to 250 questions per twin
- 85-98% prediction accuracy in customer pilots vs ~55% generic ChatGPT roleplay
- 80+ academic studies validating the methodology
- Results in minutes instead of 4-8 weeks of classic fieldwork
- API/MCP integration into ChatGPT, Claude, Copilot, and Langdock
FAQ
Is Simile self-service, or do I need to talk to sales?
Simile is sales-led only, with no self-serve signup or public plan page and no published price list.[4] The only concrete data point is a single AWS Marketplace listing showing $15,000,000 for a 36-month term, illustrative of enterprise scale rather than a typical entry price.
Is neuroflash Digital Twins free to start?
Yes. You can create an account at app.neuroflash.com and begin testing content without a sales process. API and MCP access for integrating twins into your existing AI stack is available from the Pro plan.
Can I connect neuroflash Digital Twins to ChatGPT or Claude?
Yes. From the Pro plan, neuroflash offers API and MCP access, so twins can be queried directly from ChatGPT, Claude, Copilot, Langdock, or custom agents already in your workflow.
Which platform is more accurate?
They are validated on different things. neuroflash reports 85-98% accuracy predicting reactions to marketing content specifically, including 98% across 22 product claims in the Essity case study. Simile’s peer-reviewed 85% figure measures how closely agents replicated General Social Survey answers versus human test-retest consistency, a different benchmark on a different task.[3]
My Take
Reading through Simile’s research pedigree, I do not think the $2 billion valuation is hype. The Stanford lineage is real, the CVS deployment is a genuinely impressive speed story, and the Gallup partnership gives it a credible external data source most startups lack. If I were running population-scale research for a healthcare or policy organization with a seven-figure budget, I would take Simile’s sales call.
Most teams evaluating digital twins right now are not running population-scale policy research, though. They want to know whether a LinkedIn post, a CTA, or an ad concept will land before they spend budget publishing it, and they want an answer this week, not after a multi-month enterprise sales cycle with unpublished pricing. That is the job neuroflash Digital Twins is built for: start free, test the actual content, and plug the result into the AI tools you already use.
References
[1] Unite.AI (2026): “Simile Raises More Than $200 Million at a $2 Billion Valuation to Scale Human Behavior Simulations.” https://www.unite.ai/simile-raises-more-than-200-million-at-a-2-billion-valuation-to-scale-human-behavior-simulations/
[2] TechCrunch (2026): “Synthetic User Startup Simile Raises $200M at $2B Valuation 5 Months After $100M Series A.” https://techcrunch.com/2026/07/30/synthetic-user-startup-simile-raises-200m-at-2b-valuation-5-months-after-100m-series-a/
[3] Stanford HAI / arXiv (2024): “Generative Agent Simulations of 1,000 People.” https://arxiv.org/pdf/2411.10109
[4] AWS Marketplace (2026): “Simile Product Listing.” https://aws.amazon.com/marketplace/pp/prodview-tmcdo53at4hq2
[5] Insight Innovation Ventures (2026): “Simile Just Priced the Calibration.” https://insightinnovationventures.substack.com/p/simile-just-priced-the-calibration
[6] GIGAZINE (2026): “AI Digital Twins Are Reshaping Market Research.” https://gigazine.net/gsc_news/en/20260309-ai-digital-twins-market-research-simile
[7] The Star (2026): “To Know What Your Customers Think, Just Ask Their AI Twins.” https://www.thestar.com.my/tech/tech-news/2026/07/31/to-know-what-your-customers-think-just-ask-their-ai-twins
[8] TheNextWeb (2026): “Simile Raises $200 Million to Scale Agentic Twins for AI Market Research.” https://thenextweb.com/news/simile-200-million-agentic-twins-ai-market-research